You will learn how to launch or improve your cardiac PET lab for optimal performance, quality assessment, and visual and quantitative assessment of the full range of available cardiac testing options. The course leads you through a series of comprehensive videos by leading experts featuring step-by-step instructions and case studies as well as self-assessment case-based questions. This course offers up to 19.75 CME/MOC credits.

What's Covered:

• Detailed didactic and practical aspects of operating a laboratory
• All aspects of diagnostic services encompassing visual and quantitative myocardial perfusion imaging
• Absolute measurements of myocardial blood flow using all available PET agents
• And other technical and clinical areas including:

• • Myocardial perfusion
  • Cardiac sarcoid
  • Inflammation and infection
  • Incidental findings on CT attenuation maps
  • Physics and instrumentation
  • Assessment of myocardial viability

Note: If your cardiac PET needs are more specific, you may be interested in Cardiac PET Perfusion Essentials, which focuses on myocardial perfusion including measurement of myocardial blood flow. Learn More   https://education.asnc.org/URL/CardiacPETPerfusion 

The topics that you will learn through comprehensive videos by the experts and self-assessment case-based questions include the following:

Section I: Basics of Cardiovascular PET
Module 01. Physics of Cardiovascular PET

Section II: Instrumentation
Module 02. Instrumentation of Cardiovascular PET
Module 03a. Acquisition and Processing for Cardiovascular PET
Module 03b. PET Quality Control, Corrections and Processing
Module 04. Hybrid Imaging

Section III: Cardiovascular PET Tracers
Module 05a. Cardiovascular PET Tracers Part A
Module 05b. Cardiovascular PET Tracers Part B

Section IV: How to Perform Cardiac PET
Module 06. How to Perform a 82Rb Perfusion Study
Module 07. How to Perform a 13N-NH3 Perfusion Study
Module 08. How to Perform a PET Myocardial Blood Flow Evaluation
Module 09. How to Perform an 18F FDG Viability Study
Module 10. How to Perform an 18F FDG Infection/Inflammation Study

Section V: Clinical Data
Module 11a. Cardiac PET Myocardial Perfusion Imaging Including Myocardial Blood Flow Assessment in Clinical Studies
Module 11b. Myocardial Blood Flow Assessment on PET MP
Module 12. Interpretation and Reporting of Cardiac PET Myocardial Perfusion Studies
Module 13a. Low Dose CT with Cardiac PET Perfusion
Module 13b. A Radiologist's Approach to Reviewing the CT Attenuation Correction Images for Important Incidental Findings

Section VI: Non-Perfusion PET Imaging
Module 14. Myocardial Viability with PET Clinical Data
Module 15. Cardiac Sarcoid PET Imaging Clinical Data
Module 16. Infection PET Imaging with 18F-FDG Clinical Data

Section VII: Interactive Case Studies
Module 17. Step by Step Reading Cardiac PET
Module 17a. Case Review -  82Rb PET Perfusion Imaging 
Module 17b. Case Review - Myocardial Blood Flow with 82Rb PET Imaging
Module 18. Case Review – 13N-NH3 Myocardial Perfusion Imaging
Module 19. Case review - Non-Perfusion Imaging – Viability
Module 20. Case review - Non-Perfusion Imaging – Sarcoid
Module 21. Case Review – Non-Perfusion Imaging - Infection and Inflammation

Section VIII. Establishing a PET Facility
Module 22. Planning a PET facility

This activity is targeted at physicians and is intended to provide the latest information on clinical practice and cutting-edge scientific advances in Cardiac PET imaging.

After participating in this activity, learners should be able to achieve the following:

• Differentiate the clinical value of PET versus SPECT imaging
• Describe the various hardware and software options for PET imaging and their strengths and limitations
• Examine strategies for maximizing image quality while minimizing radiation dose
• Employ procedures to ensure PET studies are acquired appropriately for clinical applications
• Explain the various PET imaging protocols and patient preparation critical to performing appropriate cardiac PET studies
• Describe how to acquire and report relative perfusion images and myocardial blood flow results from a PET perfusion study
• Detail shielding and other regulatory requirements to establish a PET facility 

This program will provide you the knowledge necessary to initiate cardiac PET imaging studies in your clinical practice to influence better outcomes in patients with CVD.

Nuclear cardiology is an important part of managing patients with cardiovascular disease. PET imaging provides improved diagnostic accuracy compared with SPECT imaging. Nuclear cardiologists, nuclear medicine physicians, radiologists and imaging technologists need to understand PET protocols and procedures and to understand and incorporate PET technology and tracers into their laboratory and establish a clinically relevant value-added service providing state-of-the-art patient care.

Evaluation Deadlines: AMA PRA Category 1 Credits™ and Participation Credits = December 31, 2027. The American Society of Nuclear Cardiology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.



Physicians: The American Society of Nuclear Cardiology designates this Journal-based CME activity for a maximum of 19.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. To receive 10 MOC points for participating in this activity, you must be a diplomate of the American Board of Internal Medicine (ABIM) and you must have an ABIM account. If you have not yet established an online account, you will need to visit the ABIM at www.abim.org, or contact ABIM via phone by calling: 1-800-441-ABIM or 215-446-3590. Mon - Fri 8:30 a.m. - 8:00 p.m. ET, Sat 9:00 a.m. - 12:00 p.m. ET.

As an accredited provider of the Accreditation Council for Continuing Medical Education (ACCME), The American Society of Nuclear Cardiology (ASNC) adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. In compliance with these standards, it is ASNC’s policy to ensure balance, independence, objectivity, and scientific merit in all its educational activities through the disclosure of all financial relationship with ineligible companies and mitigation of conflicts of interest. The financial interest or relationships requiring disclosure are outlined in ASNC’s CME Conflict of Interest Policy. All planners, reviewers, and presenters involved with this activity were required to disclose all financial relationships. The American Society of Nuclear Cardiology has reviewed this activity’s faculty disclosures and mitigated all identified conflicts of interest.

The following activity planners reported no financial relationships:
Manuel Cerqueira, MD, MASNC (Co-Chair)
Dawn Edgerton (ASNC Staff)
Michelle Klinke (ASNC Staff)

The following speakers who were involved in the development of this activity reported no financial relationships:
Talal Alnabelsi, MD
Wengen Chen, MD, PhD
Sang-Geng Cho, MD, PhD
Paul Cremer, MD
Alice Haouzi, MD
Serge Harb, MD
Robert Hendel, MD, MASNC
Marina Picinelli, PhD
Michael Steigner, MD
Randall C. Thompson, MD, MASNC
Christine Wiefels, MD, MSc, FASNC

The following faculty who were involved in the development of this activity reported the relationships:
Mouaz Al Mallah, MD, MSc, MASNC - Research Support: Siemens, GE HealthCare; Consultant: Jubilant, Pfizer, Phillips
James Case, PhD, MASNC - Intellectual property rights; Royalty: Owner: CVIT; Research Grant, Consultant: Bracco; Spectrum Dynamics: Research Grant
Panithaya Chareonthaitawee, MD - Royalty: UptoDate; Consulting Fee, Speaker: Ionetix
Sharmila Dorbala, MD, MASNC - Honoraria; Research/Grant or Contractor: Pfizer, GE Healthcare, Attralus, NovoNordisk, Alexion/AstraZeneca
Cesia Gallegos, MD, MSc - Advisory Board: Pfizer
James Galt, PhD – Royalties through the sale of Emory University sale of software for analysis of nuclear renograms
Gabriel Grossman, MD, PhD, FASNC – Research Grant, Speaker: Pfizer
Gary Heller, MD, PhD, MASNC – Advisory Board: Molecular Imaging Svcs; Scientific Advisory Board: Ge Health Care
Fabien Hyafil, MD, PhD -- Advisory Board: Stockholder; Consulting Fee: Naogen; Consulting: Pfizer; Speaker: Curium Pharma, GE Healthcare
Wael Jaber, MD – Consultant: Pfizer; Institutional Core Lab Work (No Personal Payment): Edwards Life Sciences and Boston Scientific
Edward Miller, MD, PhD, FASNC - Consulting Fee: Eidos, Alnylam, Roivant, CSL Behring; Research Grant: Alnylam, Eidos, Pfizer
Kenneth Nichols, PhD – Royalty: Syntermed
Michael Osborne, MD, FASNC – Consultant: WCG Imaging
Krishna Patel, MD, MSc – Research Grant to Institution: Jubilant RadioPharma
Aldo Schenone, MD – Research Grant, Speakers Bureau: Bristol Myers Squibb
Albert Sinusas, MD, MASNC – Institutional Grant: Siemens, Jubilant, Micro Vide, LLC; Consultant: Most Caardia LLC, Micro Vide, LLC; Material Transfer Agreement: Lantheus
Piotr Slomka, PhD, MASNC - Research Grants: Siemens Medical Systems; Consultant: Synektik; Speakers Bureau: IBA;  Royalties: Cedars Sinai Medical Center
Gary Small, MD, FASNC – UOHI Institutional Research Grant: Pfizer
Stephanie Thorn, PhD, MSc: Resesearch Grant - MicroVide 

The following reviewer(s) who was involved in the development of this activity reported no financial relationships:
Matthew Harinstein, MD, MBA, FASNC
Manuel Cerqueira, MD, MASNC